EASY BIO,Inc. (KOSDAQ:353810)
South Korea
· Delayed Price · Currency is KRW 5,200.00
-50.00 (-0.95%)
Apr 4, 2025, 3:30 PM KST
EASY BIO,Inc. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 19,604 | 15,544 | 9,131 | 10,873 |
Depreciation & Amortization | 7,505 | 3,692 | 3,763 | 2,801 |
Loss (Gain) From Sale of Assets | 114.65 | 7.04 | 0.33 | -0.9 |
Asset Writedown & Restructuring Costs | 2,241 | - | - | - |
Loss (Gain) From Sale of Investments | -680.19 | -1,118 | - | - |
Loss (Gain) on Equity Investments | -355.04 | -1,106 | -592.15 | -12.04 |
Provision & Write-off of Bad Debts | 265.07 | -524.94 | 278.77 | 193.34 |
Other Operating Activities | 1,921 | 1,958 | 1,455 | 281.15 |
Change in Accounts Receivable | -4,263 | -82.57 | -5,615 | 5,601 |
Change in Inventory | -2,173 | 3,031 | -4,871 | -2,207 |
Change in Accounts Payable | 1,032 | -23.51 | 1,907 | -1,845 |
Change in Other Net Operating Assets | 543.86 | 12,307 | -13,580 | -1,618 |
Operating Cash Flow | 25,755 | 33,684 | -8,124 | 14,066 |
Operating Cash Flow Growth | -23.54% | - | - | - |
Capital Expenditures | -4,245 | -1,886 | -1,954 | -1,834 |
Sale of Property, Plant & Equipment | 20.69 | 10.31 | 2.27 | 8.8 |
Cash Acquisitions | -79,786 | - | - | -8,876 |
Sale (Purchase) of Intangibles | -33.17 | -78.45 | -94.69 | -4.53 |
Investment in Securities | -17,045 | -39,386 | 2,561 | -9,354 |
Other Investing Activities | -0 | 0 | -0 | -0 |
Investing Cash Flow | -101,089 | -41,340 | 513.77 | -20,060 |
Short-Term Debt Issued | 72,070 | 120,996 | 76,277 | 43,778 |
Long-Term Debt Issued | 107,828 | 20,000 | 15,000 | 2,500 |
Total Debt Issued | 179,898 | 140,996 | 91,277 | 46,278 |
Short-Term Debt Repaid | -61,751 | -136,441 | -44,695 | -34,394 |
Long-Term Debt Repaid | -6,577 | -5,336 | -16,143 | -3,094 |
Total Debt Repaid | -68,328 | -141,778 | -60,838 | -37,488 |
Net Debt Issued (Repaid) | 111,570 | -782.09 | 30,438 | 8,790 |
Repurchase of Common Stock | -3,991 | - | - | - |
Dividends Paid | -3,414 | -2,626 | -2,560 | -2,560 |
Other Financing Activities | 664.65 | -0 | - | -0 |
Financing Cash Flow | 104,830 | -3,408 | 27,878 | 6,229 |
Foreign Exchange Rate Adjustments | 1,292 | 220.04 | -1,059 | 20.38 |
Miscellaneous Cash Flow Adjustments | 0 | - | -0 | 0 |
Net Cash Flow | 30,788 | -10,844 | 19,209 | 255.31 |
Free Cash Flow | 21,510 | 31,798 | -10,079 | 12,231 |
Free Cash Flow Growth | -32.35% | - | - | - |
Free Cash Flow Margin | 5.60% | 19.23% | -6.48% | 9.45% |
Free Cash Flow Per Share | 635.29 | 930.80 | -295.24 | 358.86 |
Cash Interest Paid | 5,198 | 2,893 | 1,391 | 1,210 |
Cash Income Tax Paid | 8,239 | 2,999 | 3,396 | 3,396 |
Levered Free Cash Flow | -14,367 | -10,238 | -9,100 | - |
Unlevered Free Cash Flow | -8,726 | -8,226 | -8,024 | - |
Change in Net Working Capital | 32,198 | 22,848 | 19,835 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.